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OBITUARY
In memory of Dr. Claudio Maurizio Pacella: a pioneer in clinical applications of
image-guided laser ablation
With the passing of Dr. Claudio Maurizio Pacella in January
2020, the medical community has lost one of its prominent
members and esteemed colleagues.
Dr. Pacella graduated in 1973 from the Faculty of
Medicine of the University of Rome, where he subsequently
completed his residency in radiology. Since the beginning of
his career, due to his high level of empathy with patients, he
focused his clinical attention on interventional radiology,
striving ceaselessly to perfect therapeutic strategies that
were less and less invasive for patients. In the 1980s, he
started the percutaneous treatment of liver tumors [1], and
since then he continued to apply minimally-invasive, image-
guided treatment to the care of his patients. He was among
the first in the world to apply ultrasound-guided treatment
in patients with thyroid nodules [2,3], and made outstanding
contributions to the widespread use of minimally-invasive
treatments in patients with thyroid diseases.
With an ever-inquiring mind, sensitivity, and with acute
intelligence, he started investigating the possibility of apply-
ing laser energy in the treatment of cancer patients, and his
studies and experiments led to a technique for ultrasound-
guided liver laser ablation, which he first successfully applied
in the treatment of patients with liver metastases [4].
Following this, he investigated the application of laser to thy-
roid tissue [5,6], and developed and described a technique
for laser ablation of thyroid nodules, which is now consid-
ered as current best practice for these treatments. Highly
devoted to the dissemination of knowledge and the personal
growth and career development of younger colleagues, he
unfailingly showed immense dedication and invested indefat-
igable energy in teaching and education, being responsible
for fellowship training in Italy and traveling extensively
throughout the world to visit and assist colleagues at the
beginning of their practice with laser ablation. Several physi-
cians worldwide started their practice in laser ablation thanks
to the assistance and teachings of Dr. Pacella, and a multi-
tude of patients benefitted from his groundbreaking
discoveries.
Following on from Pacella’ studies, laser ablation is today
applied in the treatment of a variety of diseases, including
not only liver and benign thyroid nodules, but also kidney,
pancreatic and thyroid tumors and, most recently benign,
and malignant prostate disease [7–14].
Even after his retirement, Dr. Pacella continued to assist
colleagues and to participate in the scientific community
providing exceptional insights into the potential of applica-
tion of thermal ablations to the care of patients. In particular,
in recent years, he developed a new technique for the treat-
ment of benign prostatic adenomas, which with the applica-
tion of laser through the transperineal route seems to
provide a new minimally-invasive effective treatment strategy
for patients [13,14]. Always extremely active and with an
incredible amount of energy, he recently participated in the
foundation of a study group on the application of minimally-
invasive treatments to the thyroid [15], and proposed to the
international community a standardized terminology to be
used in this field [16]. Furthermore, he was among the first
to propose thermal ablation as a first-line treatment modality
for the treatment of benign thyroid nodules [17]. His recent
book on the various applications of image-guided laser abla-
tions, already represents a milestone in the field of thermal
ablations [18].
The community of physicians who use the laser thermal
ablation method loses its tireless guide. From today, the
work of all of us will feel an enormous gap that was filled by
a teacher, a Counselor and, above all, a friend. It will be
everyone’s responsibility to ensure that the outstanding sci-
entific and cultural heritage left by Dr. Pacella continues to
grow and bear fruit. We will all miss him immensely and he
will never be forgotten as a pioneer and as an amiable,
good-natured, creative, and passionate person.
Our deepest sympathy and thoughts are with his wife
and his family. Together with them, his many colleagues and
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friends will hold Dr. Claudio Maurizio Pacella in grate-
ful memory.
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